Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Teva
Cantor Fitzgerald
Julphar
Boehringer Ingelheim
Deloitte
Argus Health
US Department of Justice
Cipla

Generated: April 24, 2018

DrugPatentWatch Database Preview

MITHRACIN Drug Profile

« Back to Dashboard

Which patents cover Mithracin, and when can generic versions of Mithracin launch?

Mithracin is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in MITHRACIN is plicamycin. There is one drug master file entry for this compound. Additional details are available on the plicamycin profile page.
Drug patent expirations by year for MITHRACIN
Synonyms for MITHRACIN
18378-89-7
32318-EP2280012A2
32318-EP2281815A1
32318-EP2292615A1
32318-EP2301928A1
32318-EP2301933A1
32318-EP2305640A2
32318-EP2305671A1
32318-EP2311825A1
32318-EP2311827A1
97666-60-9
A-2371
AC1L4TCM
Antibiotic LA 7017
Aurelic acid
Aureolic acid
Aurlelic acid
C12389
C52H76O24
CCRIS 5629
CHEBI:31856
D-threo-2-Pentulose, 5-deoxy-1-C-((2S,3S)-7-((2,6-dideoxy-3-O-(2,6-dideoxy-beta-D-arabino-hexopyranosyl)-beta-D-arabino-hexopyranosyl)oxy)-3-((O-2,6-dideoxy-3-C-methyl-beta-D-ribo-hexopyranosyl-(1.fwdarw.3)-O-2,6-dideoxy-beta
D00468
DB06810
DDA-(1-3)DDA-(1-6)CRH-(2-1)DDA-(3-1)DDL-(3-1)MDA
GTPL8394
HSDB 3238
LS-91528
mith
Mithracin (TN)
MITHRAMYCIN
mithramycin a
Mithramycine
Mithramycine [INN-French]
Mithramycinum
Mithramycinum [INN-Latin]
Mitramicina
Mitramicina [INN-Spanish]
Mitramycin
Mitramycine
Mitramycinum
NIJ123W41V
NSC 24559
PA 144
PA-144
Plicamicina
Plicamicina [INN-Spanish]
Plicamicina [Spanish]
plicamycin
Plicamycin (USP/INN)
Plicamycin [USAN:BAN:INN]
Plicamycin [USAN:USP:INN:BAN]
Plicamycine
Plicamycine [French]
Plicamycine [INN-French]
Plicamycinum
Plicamycinum [INN-Latin]
Plicamycinum [Latin]
Plicatomycin
SCHEMBL4517
SR-05000002335
SR-05000002335-3
UNII-NIJ123W41V

US Patents and Regulatory Information for MITHRACIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer MITHRACIN plicamycin INJECTABLE;INJECTION 050109-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Department of Justice
AstraZeneca
Accenture
Boehringer Ingelheim
Fish and Richardson
Merck
Julphar
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.